Notable Analyst Rating Changes 1/2: AF Upgraded; SUN, CSIQ, SOL, MDTH Downgraded
More News related to AF
- Astoria Financial Corporation Announces Dates for Second Quarter Earnings & Conference Call
- FBR Capital Resumes Coverage on Northeastern Banks and Thrifts (SBNY, HCBK, AF, MTB, more...)
- Astoria Federal Savings Announces 2009 Teen Photo Contest Winners
- Standard & Poor's Lowered Ratings, Revises Outlooks On 22 U.S. Banks
- AlarmForce Posts Record Revenues and Profit in the Second Quarter
More News related to CSIQ
- Canadian Solar (CSIQ) Announces 120MW of Recent Sales Orders
- Canadian Solar Announces 120MW of Recent Sales Orders
- Canadian Solar Names Gregory Ashley as Acting President of U.S. Subsidiary
- Canadian Solar to Offer Six Year Product Warranty
- Canadian Solar Completes Two Solar Demonstration Projects for Suzhou City Hall in China
More News related to MDTH
- MedCath (MDTH) Announces Resignation of CFO; Art Parker Named as Interim Replacement
- Jeff Hinton to Leave MedCath
- After-Hours Movers 5/21: SHLD, ACCL, ADSK, EXM, ARUN, SB Higher; ZUMZ, RRGB, CRM, HIBB Lower
- After-Hours Movers 5/21: SHLD, ACCL, ADSK, EXM, ARUN, SB Higher; ZUMZ, RRGB, CRM, HIBB Lower
- MedCath (MDTH) Reports Q2 Adj-EPS of $0.31, Beats by 11c
UPGRADES:
JP Morgan upgrades Astoria Financial (NYSE: AF) from Underperform to Neutral.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Soleil Securities downgrades Sunoco, Inc. (NYSE: SUN) from Buy to Hold. Price target $45.
Piper Jaffray downgrades Canadian Solar (Nasdaq: CSIQ) from Neutral to Sell.
Piper Jaffray downgrades ReneSola Ltd. (NYSE: SOL) from Buy to Neutral. Price target lowered from $7.50 to $5.00.
Deutsche Bank downgrades MedCath Corporation (Nasdaq: MDTH) from Buy to Hold. Price target lowered from $14 to $12.50.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
Related Categories
Special ReportsStocks Mentioned
+21.10
-0.39Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
